Poolbeg Pharma CEO Jeremy Skillington and Liam discuss the execution plan for their upcoming Phase 2a trial of POLB 001, a promising candidate in cancer immunotherapy. They detail the trial design, the selection of clinical partners, and the potential impact of the drug. Jeremy also outlines what investors can expect in the near term as the programme advances.

Watch on Youtube 

Pinnacle Silver and Gold has released its latest set of sample results from exploration at and around its two historic mine sites in Mexico. The results showed high grade silver and gold, and suggested a continuity of mineralisation between the surface and the underground former workings. A new vein is also under investigation nearby, and allowing for permits underground drilling could start fairly soon. Chief executive Bob Archer joins us with the full story

Watch on YouTube

In this interview, CEO Paul Mathieson outlines Amazing AI’s dual strategy of regulated US consumer lending and international AI-driven credit services, while explaining the company’s updated crypto treasury policy and its plans for growth in emerging markets.

European Green Transition's #EGT interims show plenty of activity in the first half of 2025, and signposts to plenty more in the coming months. CFO Jack Kelly joins Vox to talk us through the latest on Olserum, and also elaborates on just what the company means when it says it's looking for acquisitions beyond the green economy

In this positive interview, CEO Steve McQuillan & CFO Stephen King of Avingtrans take me through today’s strong FY’25 results and in line guidance.

00:00 Secular growth drivers and current demand picture

06:45 Orderbook & financial highlights

10:15 Progress with medical division

14:05 Possible M&A and future corporate exits

1530 FY26 outlook and closing remarks

hVIVO CEO Mo Khan discusses the company’s H1 2025 results, the impact of CRO market headwinds, and progress on integrating CRS and Cryostore. He also touches on the strategic value of new Chairman Shaun Chilton and outlines what investors can expect for the rest of the year.

In this positive interview, CEO Adam Holland & Group Finance Director Will Wilkins of MPAC  take me through today’s H1’25 results and in line FY’25 guidance.

00:00 Order intake and current demand

07:00 Financial highlights

09:45 US consolidation and integration of acquisitions

13:50 Pension buy-in, FY’25 outlook and net debt

16:20 Closing remarks

Greg Martyr, executive chairman of Capital Metals, joins Vox for an update on progress at the company's Taprobane mineral sands project in Sri Lanka. Capital Metals is nearing a final investment decision for Taprobane, which looks to be a high-margin, low cost project, with plenty of upside. Upcoming results from a substantial drilling campaign should increase the size of the resource substantially.

Fintel CEO Matt Timmins reported strong half-year results with revenues up 19% and EBITDA up 17%. He highlighted growth in recurring SaaS revenues, the streamlined two-division structure, and successful integration of acquisitions.

Howard McLaughlin, interim chief executive of Mosman Oil & Gas, joins Vox for an update, following the release of a new independent consultant's report on its Sagebrush helium project in the USA. Significant helium is confirmed at Sagebrush, as well as substantial showings of natural gas and carbon dioxide. The potential dollar valuation of the project far exceeds the company's current market capitalisation, notwithstanding the recent share price surge.